High FOSL1 expression is associated with poor overall survival in lung adenocarcinoma, pancreatic adenocarcinoma, clear cell renal cell carcinoma, sarcoma, low grade glioma, glioblastoma, head and neck squamous carcinoma (HNSCC), and uveal melanoma (Fig. 7A). This evidence concerns the gene FOSL1 and sarcoma.